About: CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.75 (+5.42%)
CALC NASDAQ CalciMedica, Inc. Common Stock
CalciMedica, Inc. Common Stock share price
Atividade de preço de CALC
Último preço
$ 1,750
Variação (24h)
0,09 USD (5,42%)
Volume
105.68K
Volume (média 4 sem.)
-
Abertura
$ 1,83
Variação do dia
$ 1,53 - $ 1,83
Fechamento anterior
$ 1,66
Último negócio
29 Oct, 8:24 pm GMT+0
Atrasado
29 Oct, 8:24 pm GMT+0
CALC price performance
Atrasado
29 Oct, 8:24 pm GMT+0
quote.marketSignals